Identifying Key The...
Health Care: Drugs
Emisphere Technologies (EMIS: OTC)
$0.31 -0.01 | -3.12%
02/10/12 - 11:31 AM ET
185.25K / 502.70K
Vol / Avg. Vol:0.33 / 0.32
Open / Prev. Close:0.31 - 0.35
Today's Range:0.14 - 1.99
52 Wk Range:16.28%
Performance YTD:TheStreet Rating:
Portfolios with EMIS
- Portfolio NameUser Type
- ContributorBarron's Insider Purchases ...
- UserValue Picks 2009
- UserRadex
- Userbrighto Portfolio 1
- UserBollywood of Wallstreet - 2008
- Userbigwilly69 Portfolio 1
- Userscjs4r speculative
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- UserBENITRANS BP ( SUPRATRADE)
Latest EMIS Headlines from TheStreet
- Emisphere Technologies, Inc. Announces Postponement Of Annual Earnings Release And Conference Call 03.14.11 | 07:03 pm
- Emisphere Announces Fourth Quarter And Full Year 2010 Earnings Conference Call 03.08.11 | 09:03 am
- Emisphere Technologies And Michael V. Novinski Mutually Agree To The Non-Renewal Of Employment Contract 02.28.11 | 04:02 pm
- Novo Nordisk A/S And Emisphere Technologies, Inc. Announce License Agreement To Develop Oral Formulation Of Insulin For Diabetes 12.21.10 | 05:12 am
- Emisphere Technologies To Present At 2010 Maxim Group Growth Conference 11.12.10 | 09:11 am
- Emisphere Technologies Announces Financial And Operational Results For The Third Quarter And First Nine Months Of 2010 11.10.10 | 05:11 pm
- Emisphere Technologies, Inc. Announces Third Quarter 2010 Earnings Conference Call 11.04.10 | 09:11 am
- Emisphere Technologies Reports Notification Of Top Level Results On Phase III Study Of Oral Calcitonin In Osteoarthritis Patients 10.22.10 | 09:10 am
- Emisphere Reports Positive Clinical Results For Its Oral Drug Delivery Technology In Appetite Suppression Study 09.17.10 | 08:09 am
- Emisphere Technologies To Present At Rodman & Renshaw 12th Annual Healthcare Conference 09.07.10 | 09:09 am
Press Releases for EMIS
- Novo Nordisk A/S And Emisphere Technologies, Inc. Announce License Agreement To Develop Oral Formulation Of Insulin For Diabetes - PR Newswire 12.21.10 | 05:12 am
- Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen® Technology - Business Wire 03.18.10 | 08:03 am
- Emisphere Announces Fourth Quarter/Year End 2009 Earnings Call - Business Wire 03.17.10 | 08:03 am
- Emisphere Technologies Announces Extension Of Maturity Date For Convertible Promissory Note - Business Wire 02.24.10 | 08:02 am
- Emisphere To Present At 12th Annual BIO CEO & Investor Conference - Business Wire 02.02.10 | 09:02 am
Partner Headlines for EMIS
- Emisphere: Set to Shake Up the B12 Market - Seeking Alpha 04.30.10 | 05:04 pm
